Vitamin D in the Treatment of Primary Restless Legs Syndrome
Vitamin D in the Treatment of Primary Restless Legs Syndrome: 12 Weeks, Triple-blinded, Randomized, Placebo-controlled Trial
Sponsor: King AbdulAziz City for Science and Technology
Listed as NCT02256215, this PHASE2/PHASE3 trial focuses on Restless Legs Syndrome and remains ongoing. Sponsored by King AbdulAziz City for Science and Technology, it has been updated 7 times since 2015, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Unknown PHASE2/PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE2/PHASE3
Status: Unknown Status → Unknown · Phase: PHASE2_PHASE3 → PHASE2/PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status PHASE2_PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Unknown Status PHASE2_PHASE3
-
Feb 2018 — Jun 2018 [monthly]
Unknown Status PHASE2_PHASE3
Status: Not Yet Recruiting → Unknown Status
▶ Show 2 earlier versions
-
Feb 2017 — Feb 2018 [monthly]
Not Yet Recruiting PHASE2_PHASE3
-
Jan 2017 — Feb 2017 [monthly]
Not Yet Recruiting PHASE2_PHASE3
First recorded
Dec 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- King AbdulAziz City for Science and Technology
- King Abdulaziz University
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.